Tags

Type your tag names separated by a space and hit enter

Voice outcome measures after flexible endoscopic injection laryngoplasty.
World J Otorhinolaryngol Head Neck Surg. 2018 Jun; 4(2):130-134.WJ

Abstract

Objective

To report voice outcome measures after injection laryngoplasty using the transnasal or transoral flexible endoscopic technique.

Methods

A retrospective review of all patients who underwent flexible endoscopic injection laryngoplasty between June 2010 and August 2016 was carried out. Only those patients who had pre- and post-injection voice outcome measures recorded were included. Voice outcome measures recorded included perceptual voice evaluation using GRBAS, Voice Handicap Index-10 (VHI-10), maximum phonation time (MPT) and closed quotient (CQ) before and after treatment.

Results

Forty-six patients were identified, of which 32 had pre- and post-injection voice outcome measures recorded. There were 19 males and 13 females. The mean age was 56.97 years (range 20-86 years) and the most common indication was unilateral vocal fold paralysis. Thirteen patients had a transnasal flexible endoscopic injection), while 19 patients were injected transorally. Following injection laryngoplasty, there was significant improvement in the mean grade of dysphonia (2.81 vs. 1.22, P < 0.01, roughness (2.44 vs. 1.34, P < 0.01), breathiness (2.72 vs. 1.13, P < 0.01), asthenia (2.78 vs. 1.06, P < 0.01), and strain (2.44 vs. 1.19, P < 0.01), MPT (3.85 s vs. 9.85 s, P < 0.01) and mean CQ (0.19 vs. 0.46, P < 0.01). There was also a decrease in the mean VHI-10 score (33.31 vs. 7.94, P < 0.01).

Conclusion

s: Patients achieved significant improvement in both subjective and objective voice measures after flexible endoscopic injection laryngoplasty via the nasal or transoral route. Voice outcomes were comparable to those reported for other approaches. This technique provides an alternative approach for the management of patients with vocal fold paralysis or glottal insufficiency.

Authors+Show Affiliations

Department of Otolaryngology and Head & Neck Surgery, American University of Beirut-Medical Center, Lebanon.Department of Anesthesiology, American University of Beirut-Medical Center, Lebanon.Department of Otolaryngology and Head & Neck Surgery, American University of Beirut-Medical Center, Lebanon.Department of Otolaryngology and Head & Neck Surgery, American University of Beirut-Medical Center, Lebanon.Department of Otolaryngology, Head & Neck Surgery, Rafic Hariri University Hospital, Lebanon.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

30101223

Citation

Hamdan, Abdul-Latif, et al. "Voice Outcome Measures After Flexible Endoscopic Injection Laryngoplasty." World Journal of Otorhinolaryngology - Head and Neck Surgery, vol. 4, no. 2, 2018, pp. 130-134.
Hamdan AL, Rizk M, Khalifee E, et al. Voice outcome measures after flexible endoscopic injection laryngoplasty. World J Otorhinolaryngol Head Neck Surg. 2018;4(2):130-134.
Hamdan, A. L., Rizk, M., Khalifee, E., Ziade, G., & Kasti, M. (2018). Voice outcome measures after flexible endoscopic injection laryngoplasty. World Journal of Otorhinolaryngology - Head and Neck Surgery, 4(2), 130-134. https://doi.org/10.1016/j.wjorl.2018.04.005
Hamdan AL, et al. Voice Outcome Measures After Flexible Endoscopic Injection Laryngoplasty. World J Otorhinolaryngol Head Neck Surg. 2018;4(2):130-134. PubMed PMID: 30101223.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Voice outcome measures after flexible endoscopic injection laryngoplasty. AU - Hamdan,Abdul-Latif, AU - Rizk,Marwan, AU - Khalifee,Elie, AU - Ziade,Georges, AU - Kasti,Maher, Y1 - 2018/07/04/ PY - 2018/04/13/received PY - 2018/04/17/accepted PY - 2018/8/14/entrez PY - 2018/8/14/pubmed PY - 2018/8/14/medline KW - Flexible endoscopic KW - Injection KW - Laryngoplasty KW - Transnasal KW - Transoral KW - Vocal fold paralysis SP - 130 EP - 134 JF - World journal of otorhinolaryngology - head and neck surgery JO - World J Otorhinolaryngol Head Neck Surg VL - 4 IS - 2 N2 - Objective: To report voice outcome measures after injection laryngoplasty using the transnasal or transoral flexible endoscopic technique. Methods: A retrospective review of all patients who underwent flexible endoscopic injection laryngoplasty between June 2010 and August 2016 was carried out. Only those patients who had pre- and post-injection voice outcome measures recorded were included. Voice outcome measures recorded included perceptual voice evaluation using GRBAS, Voice Handicap Index-10 (VHI-10), maximum phonation time (MPT) and closed quotient (CQ) before and after treatment. Results: Forty-six patients were identified, of which 32 had pre- and post-injection voice outcome measures recorded. There were 19 males and 13 females. The mean age was 56.97 years (range 20-86 years) and the most common indication was unilateral vocal fold paralysis. Thirteen patients had a transnasal flexible endoscopic injection), while 19 patients were injected transorally. Following injection laryngoplasty, there was significant improvement in the mean grade of dysphonia (2.81 vs. 1.22, P < 0.01, roughness (2.44 vs. 1.34, P < 0.01), breathiness (2.72 vs. 1.13, P < 0.01), asthenia (2.78 vs. 1.06, P < 0.01), and strain (2.44 vs. 1.19, P < 0.01), MPT (3.85 s vs. 9.85 s, P < 0.01) and mean CQ (0.19 vs. 0.46, P < 0.01). There was also a decrease in the mean VHI-10 score (33.31 vs. 7.94, P < 0.01). Conclusion: s: Patients achieved significant improvement in both subjective and objective voice measures after flexible endoscopic injection laryngoplasty via the nasal or transoral route. Voice outcomes were comparable to those reported for other approaches. This technique provides an alternative approach for the management of patients with vocal fold paralysis or glottal insufficiency. SN - 2589-1081 UR - https://www.unboundmedicine.com/medline/citation/30101223/Voice_outcome_measures_after_flexible_endoscopic_injection_laryngoplasty_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S2095-8811(18)30061-1 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.